Mirae Asset Global ETFs Holdings’s Palvella Therapeutics PVLA Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio PVLA Stock Details PVLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$976K	Buy	6,372 +1,684	+36%	+$204K	﹤0.01%	1640
2026 Q1	$570K	Buy	4,688 +382	+9%	+$39.8K	﹤0.01%	1825
2025 Q4	$446K	Buy	4,306 +1,132	+36%	+$96.6K	﹤0.01%	1947
2025 Q3	$199K	Sell	3,174 -576	-15%	-$25.7K	﹤0.01%	2322
2025 Q2	$84.5K	Buy	+3,750	New	+$88K	﹤0.01%	2691

Other funds holding PVLA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's PVLA Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Palvella Therapeutics (PVLA) stake by 36% in Q2 2026, buying an estimated $204K and bringing the position to 6,372 shares worth $976K. The position accounts for ﹤0.01% of the portfolio, ranked #1640.

Mirae Asset Global ETFs Holdings first reported a position in PVLA in Q2 2025 and has held it in 5 quarters since. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

Mirae Asset Global ETFs Holdings held 6,372 shares of Palvella Therapeutics worth $976K as of Q2 2026.
Mirae Asset Global ETFs Holdings bought 1,684 Palvella Therapeutics shares in Q2 2026, an estimated $204K.
Palvella Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1640 holding.
Mirae Asset Global ETFs Holdings first reported a position in Palvella Therapeutics in Q2 2025 and has held it in 5 quarters since.
196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.